Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4,946,087
-
Shares change
-
-1,561,858
-
Total reported value, excl. options
-
$23,495,067
-
Value change
-
-$8,902,015
-
Put/Call ratio
-
9.61%
-
Number of buys
-
19
-
Number of sells
-
-37
-
Price
-
$4.75
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2022
70 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2022.
AVITA Medical, Inc. - Common Stock (RCEL) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,946,087 shares
of 26,475,256 outstanding shares and own 18.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,147,755 shares), PURA VIDA INVESTMENTS, LLC (741,875 shares), FARALLON CAPITAL MANAGEMENT LLC (580,000 shares), BlackRock Inc. (476,890 shares), RENAISSANCE TECHNOLOGIES LLC (327,280 shares), MILLENNIUM MANAGEMENT LLC (267,163 shares), GEODE CAPITAL MANAGEMENT, LLC (250,307 shares), AMERIPRISE FINANCIAL INC (153,957 shares), RTW INVESTMENTS, LP (106,667 shares), and Ergoteles LLC (101,963 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.